OpenVSafe by OpenVAERS
Search V-safe

BXN-70492-15983

2 vaccinations 2 coded responses 3 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
837 / ID
Registered
2020-12-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-28
    Registered in v-safe
  2. 2020-12-28
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-28
    Survey response — day 0, dose 1
    MedDRA: Hot flush — Feeling: Good · Fever
    Free text: Feel like I'm having hot flashes about 8 hours after 1st dose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  6. 2021-07-20
    Survey response — 6 months, dose 2
    MedDRA: Emergency care, Impaired work ability, Office visit, Skin discolouration — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Symptoms: Discoloration of toes starting within 2 weeks after 1st immunization, 3 separate episodes all starting after vaccine, last episode the worst -Within 5 weeks post 2nd dose - apple area next similar to COVID toes, no COVID. Echo and CT angiogram · Healthcare visit (other): ER after initial discoloration, 2 Dermatology visits, 2-3 Primary care visits, Echo and CT angiogram outpatient Appts, 5 weeks off work FMLA, 4 consults with Rheumatologist and awaiting appointment with Cardiovascular doctor
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-07-20
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-07-26
  9. 2021-08-03
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12020-12-28Pfizer-BioNTech
22021-01-19Pfizer-BioNTech

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-28

Systemic reaction (other): Feel like I'm having hot flashes about 8 hours after 1st dose

Release 9 — 6 months, dose 2

2021-07-20

Symptoms: Discoloration of toes starting within 2 weeks after 1st immunization, 3 separate episodes all starting after vaccine, last episode the worst -Within 5 weeks post 2nd dose - apple area next similar to COVID toes, no COVID. Echo and CT angiogram
Healthcare visit (other): ER after initial discoloration, 2 Dermatology visits, 2-3 Primary care visits, Echo and CT angiogram outpatient Appts, 5 weeks off work FMLA, 4 consults with Rheumatologist and awaiting appointment with Cardiovascular doctor

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOEmergency care · · ✓
HCVOImpaired work ability · · ✓
HCVOOffice visit · · ✓
HCVOSkin discolouration · · ✓
SDSkin discolouration · · ✓
SROHot flush ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release